See every side of every news story
Get Started
SubscribeLogin
Pope Francis
Basketball
Vatican
Wrestling
MLS
Baseball
Donald Trump
Hockey
Tennis
Israel-Hamas Conflict
Hamas
Ukraine War
Published • loading... • Updated

Is Rocket Lab USA Stock a Buy Now? @themotleyfool #stocks $RKLB

Summary by BizToc
It's been a rough start to 2025 for Merck (NYSE: MRK) shareholders following a less-than-stellar fourth-quarter earnings report. Even as the pharmaceutical giant exceeded Wall Street estimates with 7% revenue growth and earnings per share (EPS) of $1.72 for the quarter ended Dec. 31, weak sales in…

2 Articles

All
Left
1
Center
Right
The Motley FoolThe Motley Fool

Is Rocket Lab USA Stock a Buy Now? @themotleyfool #stocks $RKLB

·Alexandria, United States
Read Full Article
BizTocBizToc

Is Merck Stock a Buy?

It's been a rough start to 2025 for Merck (NYSE: MRK) shareholders following a less-than-stellar fourth-quarter earnings report. Even as the pharmaceutical giant exceeded Wall Street estimates with 7% revenue growth and earnings per share (EPS) of $1.72 for the quarter ended Dec. 31, weak sales in…

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources lean Left
100% Left
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

BizToc broke the news in on Saturday, February 22, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Merck

Merck

United States

United States

News
For You
Search
BlindspotLocal